Skip to main content
Article
Idarubicin, cytarabine, and pravastatin as induction therapy for untreated acute myeloid leukemia and high‐risk myelodysplastic syndrome
American Journal of Hematology (2015)
  • Mazyar Shadman, Fred Hutchinson Cancer Research Center
  • Raya Mawad, Fred Hutchinson Cancer Research Center
  • Carol Dean, Fred Hutchinson Cancer Research Center
  • Tara L. Chen, University of Washington
  • Kathleen Shannon-Dorcy, Fred Hutchinson Cancer Research Center
  • Vicky Sandhu, Fred Hutchinson Cancer Research Center
  • Paul C. Hendrie, University of Washington
  • Bart L. Scott, Fred Hutchinson Cancer Research Center
  • Rol B. Walter, Fred Hutchinson Cancer Research Center
  • Pamela S. Becker, Fred Hutchinson Cancer Research Center
  • John M. Pagel, Fred Hutchinson Cancer Research Center
  • Elihu H. Estey, Fred Hutchinson Cancer Research Center
Publication Date
January 6, 2015
DOI
10.1002/ajh.23981
Citation Information
Mazyar Shadman, Raya Mawad, Carol Dean, Tara L. Chen, et al.. "Idarubicin, cytarabine, and pravastatin as induction therapy for untreated acute myeloid leukemia and high‐risk myelodysplastic syndrome" American Journal of Hematology Vol. 90 Iss. 6 (2015) p. 483 - 486
Available at: http://works.bepress.com/kathleen_shannondorcy/13/